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A pilot project to screen 1000 woman aged between 18 and 30 years for genital chlamydia infection in the Nova Gorica region of Slovenia is underway.
In the first national survey of sexual lifestyles, attitude and health conducted in 1999-2001 in Slovenia, genital chlamydia prevalence was found to be 3.6% in the 25-34 age group and 4.1% in the 18-24 age group for both men and women [1] . For the Nova Gorica screening project, we are targeting women aged between 18-30 to detect asymptomatic infections and to treat them and their partners. Although the evidence suggests that the prevalence in men is the same as women within the target age groups, there is no evidence that screening men influences the prevalence of genital chlamydia infection in women.
At this stage, and with limited available resources for the pilot, we decided to focus on women, who are more vulnerable to longer term sequelae of untreated infections. Screening and treatment is the most effective way to minimise the prevalence and transmission of genital chlamydia and pelvic inflammatory disease.
In Slovenia, genital chlamydia testing of women is mainly done by gynaecologists at primary healthcare facilities (gynaecological dispensaries). Some testing is also done at hospital gynaecology departments. Men are tested by dermatovenerologists in primary healthcare facilities, and some at a hospital dermatovenerological clinic. Genitourinary medicine is not accessible without referral from either gynaecologists or general practitioners.
Genital chlamydia infection is a notifiable disease by law, with all cases reported anonymously using soundex coding since 2001 [2] .
Chlamydia epidemiology in the Nova Gorica region
In the Nova Gorica Health Region of Slovenia (103 000 inhabitants) between 2000 and 2004, 715 specimens, the majority of which were endocervical, were tested for Chlamydia trachomatis. There were 132 positive tests (18.5%) (Figures 1 and 2 ). 
Because all women must register to use gynaecology services, there is precise information on the number of women within certain age categories. There are 4700 registered women aged 18-24 years and 4456 registered women aged 25-30 years. From this, we estimated that a sample of 1000 would be realistically achievable within the short time period that the project is running.
All women between the ages 18-30 years who consult gynaecologists in Nova Gorica region are being asked to participate in this project. If they agree, and give written informed consent, they are invited to provide a first void urine specimen for chlamydia testing. They are also asked to complete a short questionnaire on their social and demographic background and on their sexual behavioural [2] .
On the basis of the FVU specimen test results, the prevalence of Chlamydia trachomatis urogenital infections in different age groups, and the sociodemographic and sexual behavioural risk factors for chlamydia urogenital infections can be estimated.
Diagnostic methods
Since 1986, direct fluorescent antibody (DFA) testing has been used to detect genital chlamydia infection in Nova Gorica. Project funding has obtained Mastercycler equipment which enables chlamydia detection by polymerase chain reaction (PCR); PCR is highly sensitive and is much more effective than DFA testing of individuals with asymptomatic infections.
Contribution to prevention work
Diagnosis, prevention and treatment of chlamydia require a multidisciplinary approach by health professionals. With the screening results, we aim to inform and promote screening of chlamydia infection among regional gynaecologists and affect public health policy on the issue.
Funding is provided through the Phare programme (http:// europa.eu.int/comm/enlargement/pas/phare/intro.htm), and one of the conditions of Phare funding is collaboration between European countries. This project is a collaboration with the Azienda per I Servizi Sanitari n. 2 "Isontina" Gorizia and Comune di Gorizia -Servizi Sociali in Italy, and leaflets giving information on genital chlamydia infection (symptoms, transmission, diagnosis, treatment, follow-up, prevention and safe sex) have been produced in both Slovene and Italian. These leaflets will be distributed in gynaecological dispensaries, schools, and to the media in Nova Gorica, Slovenia and the Gorizia region in Italy, with the intention of raising chlamydia awareness in young people.
The project started in October 2004 and is due to finish by October 2005. We hope that our results will provide support for the introduction of nationwide chlamydia screening in Slovenia.
